¼¼°èÀÇ ¾È±¸ ÀÓÇöõÆ® ½ÃÀå
Ocular Implants
»óǰÄÚµå : 1565145
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¾È±¸ ÀÓÇöõÆ® ½ÃÀåÀº 2030³â±îÁö 203¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 151¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾È±¸ ÀÓÇöõÆ® ¼¼°è ½ÃÀåÀº 2023-2030³â°£ ¿¬Æò±Õ 4.3% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 203¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ³ì³»Àå ÀÓÇöõÆ®´Â CAGR 4.7%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 65¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àΰø¼öÁ¤Ã¼ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 40¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.0%·Î ¼ºÀå Àü¸Á

¹Ì±¹ ¾È±¸ ÀÓÇöõÆ® ½ÃÀåÀº 2023³â 40¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 32¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 4.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.9%¿Í 3.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ 3.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¾È±¸ ÀÓÇöõÆ® ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¾È±¸ ÀÓÇöõÆ®¶õ ¹«¾ùÀΰ¡?

¾È±¸ ÀÓÇöõÆ®´Â ¾È±¸ÀÇ ¼Õ»óµÈ ºÎºÐÀ̳ª ±â´É Àå¾Ö¸¦ ´ëüÇϰųª Áö¿øÇϱâ À§ÇØ °í¾ÈµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÓÇöõÆ®´Â ÁÖ·Î ¹é³»Àå, ³ì³»Àå, Ȳ¹Ýº¯¼º, ¸Á¸·Áúȯ µî ´Ù¾çÇÑ ¾ÈÁúȯÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀϹÝÀûÀÎ ¾È±¸ ÀÓÇöõÆ®¿¡´Â ¹é³»Àå ¼ö¼ú ÈÄ ÀÚ¿¬ ¼öÁ¤Ã¼¸¦ ´ëüÇÏ´Â Àΰø¼öÁ¤Ã¼(IOL)¿Í ÀϺΠ½Ç¸í ȯÀÚ¿¡°Ô ºÎºÐÀûÀÎ ½Ã·ÂÀ» ȸº¹½ÃŰ´Â ¸Á¸· ÀÌ½Ä µîÀÌ ÀÖ½À´Ï´Ù. ÀÓÇöõÆ®´Â ÀϹÝÀûÀ¸·Î ½Ç¸®ÄÜÀ̳ª Æú¸®¸ÞÆ¿¸ÞŸũ¸±·¹ÀÌÆ®(PMMA)¿Í °°Àº »ýüÀûÇÕ¼º ¹°Áú·Î ¸¸µé¾îÁ® ¾È±¸ Á¶Á÷°ú ¿øÈ°ÇÏ°Ô ÅëÇյ˴ϴÙ. ³ëÈ­¿¡ µû¸¥ ¾ÈÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÇ·á ±â¼úÀÇ ¹ßÀüÀ¸·Î ½Ã·Â °³¼±°ú ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ ¾È±¸ ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¾È±¸ ÀÓÇöõÆ® ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â »õ·Î¿î Æ®·»µå´Â?

¾È±¸ ÀÓÇöõÆ® ½ÃÀåÀº ¸î °¡Áö ÁÖ¸ñÇÒ ¸¸ÇÑ Æ®·»µå¿¡ ÀÇÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. °¡Àå ´«¿¡ ¶ç´Â °Í Áß Çϳª´Â ƯÈ÷ ¼±Áø±¹ÀÇ °í·ÉÈ­ Àα¸ Áõ°¡·Î ¹é³»Àå, ³ì³»Àå µî ³ëÈ­¿¡ µû¸¥ ¾È°ú ÁúȯÀÌ ±ÞÁõÇϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Åë°èÇÐÀû º¯È­´Â Àΰø¼öÁ¤Ã¼(IOL)¿Í ³ì³»Àå ¹è¼öÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Å« Æ®·»µå´Â ¹é³»Àå ±³Á¤»Ó¸¸ ¾Æ´Ï¶ó ³ë¾È ¹× ±âŸ ±¼Àý ÀÌ»ó¿¡ ´ëÀÀÇÏ¿© ¾È°æÀÇ Çʿ伺À» ¾ø¾Ö´Â ´ÙÃÊÁ¡ Àΰø¼öÁ¤Ã¼ ¹× ¼ö¿ë¼º Àΰø¼öÁ¤Ã¼¿Í °°Àº ÷´Ü ÀÓÇöõÆ® ±â¼úÀÇ µîÀåÀÔ´Ï´Ù. ¶ÇÇÑ, ÇöÀç ÁøÇà ÁßÀÎ ¸Á¸· ÀÌ½Ä ¹× Àΰø ½Ã·Â ÀåÄ¡ ¿¬±¸´Â ¸Á¸· ÅðÇ༺ ÁúȯÀÇ Ä¡·á¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖÀ¸¸ç, ÇöÀç Ä¡·á ¿É¼ÇÀÌ Á¦ÇѵǾî Àִ ȯÀڵ鿡°Ô Èñ¸ÁÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ±âÁ¸ ½ÃÀå°ú ½ÅÈï ½ÃÀå ¸ðµÎ¿¡¼­ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀº ¾î¶»°Ô ¾È±¸ À̽ļúÀ» ¹ßÀü½ÃÄ×À»±î?

±â¼úÀÇ ¹ßÀüÀº ¾È±¸ ÀÓÇöõÆ®ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä Çõ½Å Áß Çϳª´Â ¹é³»Àå»Ó¸¸ ¾Æ´Ï¶ó ³­½Ã, ³ë¾È µî ¿©·¯ À¯ÇüÀÇ ±¼Àý ÀÌ»óÀ» ±³Á¤ÇÏ¿© ´õ ³ôÀº ½Ã·Â °á°ú¸¦ Á¦°øÇÏ´Â ÇÁ¸®¹Ì¾ö Àΰø¼öÁ¤Ã¼ÀÇ °³¹ßÀÔ´Ï´Ù. ¶ÇÇÑ, ÆèÅä¼¼ÄÁµå ·¹ÀÌÀú Áö¿ø ¹é³»Àå ¼ö¼ú°ú °°Àº ÃÖ¼Òħ½À ¼ö¼ú ±â¼úÀº ¾È±¸ ÀÓÇöõÆ® ¼ö¼úÀ» º¸´Ù ¾ÈÀüÇϰí Á¤È®ÇÏ°Ô ¸¸µé¾î ȯÀÚÀÇ È¸º¹ ½Ã°£À» ´ÜÃà½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç·á°úÇÐÀÇ ¹ßÀüÀ¸·Î ¿°ÁõÀ̳ª °ÅºÎ¹ÝÀÀ°ú °°Àº ¼ö¼ú ÈÄ ÇÕº´Áõ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â ³»±¸¼º°ú »ýüÀûÇÕ¼ºÀÌ ¶Ù¾î³­ ÀÓÇöõÆ® Àç·á°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¸Á¸· À̽Ĵ ´«ºÎ½Å ¹ßÀüÀ» °ÅµìÇϰí ÀÖÀ¸¸ç, Argus II¿Í °°Àº ÀåÄ¡´Â ¸Á¸·»ö¼Òº¯¼ºÁõÀ¸·Î ÀÎÇØ ½Ã·ÂÀ» ÀÒÀº ȯÀڵ鿡°Ô ºÎºÐÀûÀÎ ½Ã·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú °³¹ßÀº ¾È°ú ºÐ¾ß¿¡ Çõ¸íÀ» °¡Á®¿Ô°í, ÷´Ü ¾È±¸ ÀÓÇöõÆ®...

¾È±¸ ÀÓÇöõÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¾È±¸ ÀÓÇöõÆ® ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿ì¼±, ³ëÈ­¿¡ µû¸¥ ¾ÈÁúȯ, ƯÈ÷ ¹é³»Àå°ú ³ì³»ÀåÀÇ À¯º´·ü Áõ°¡´Â ¼ö¼úÀû À̽ÄÀ» ÅëÇØ °¡Àå È¿°úÀûÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖ´Â ¾ÈÁúȯ Áõ°¡°¡ Å« ¼ºÀå µ¿·ÂÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ ¾È°ú ÀÇ·á¿¡ ´ëÇÑ Àνİú Á¢±Ù¼ºÀÌ Çâ»óµÇ¸é¼­ ¾È±¸ ÀÓÇöõÆ® ȯÀÚ ±â¹ÝÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ½Ã·Â ¹®Á¦¸¦ ÇØ°áÇϴ ÷´Ü Àΰø¼öÁ¤Ã¼(IOL)ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Áø´Ü µµ±¸ÀÇ °³¼±°ú ÃÖ¼Ò Ä§½ÀÀû ±â¼ú µî ¾È°ú ¼ö¼úÀÇ ±â¼ú ¹ßÀüÀº ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ¸Á¸· ÀÌ½Ä ¹× ±âŸ Çõ½ÅÀûÀÎ ½Ã·Â ȸº¹ ±â¼úÀÇ ¹ßÀüÀº °ú°Å¿¡´Â Ä¡·áÇÒ ¼ö ¾ø¾ú´ø ȯÀڵ鿡°Ô »õ·Î¿î Èñ¸ÁÀ» °¡Á®´ÙÁÖ¸ç ÀÌ ºÐ¾ß ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(17°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ocular Implants Market to Reach US$20.3 Billion by 2030

The global market for Ocular Implants estimated at US$15.1 Billion in the year 2023, is expected to reach US$20.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Glaucoma Implants, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$6.5 Billion by the end of the analysis period. Growth in the Intraocular Lenses segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 4.0% CAGR

The Ocular Implants market in the U.S. is estimated at US$4.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 4.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Ocular Implants Market - Key Trends & Drivers Summarized

What Are Ocular Implants and How Do They Work?

Ocular implants are medical devices designed to replace or support damaged or dysfunctional parts of the eye. These implants are primarily used to treat various eye conditions, including cataracts, glaucoma, macular degeneration, and retinal disorders. Some common types of ocular implants include intraocular lenses (IOLs), which are used to replace the natural lens after cataract surgery, and retinal implants, which help restore partial vision to individuals with certain forms of blindness. The implants are typically made from biocompatible materials like silicone or polymethylmethacrylate (PMMA), ensuring they integrate seamlessly with the eye's tissues. With the increasing prevalence of age-related eye conditions and advancements in medical technology, the demand for ocular implants continues to grow as they offer improved vision and enhanced quality of life for patients.

What Emerging Trends are Influencing the Ocular Implants Market?

The ocular implants market is being shaped by several notable trends. One of the most prominent is the growing aging population, particularly in developed countries, which has led to a surge in age-related eye disorders such as cataracts and glaucoma. This demographic shift is driving an increased demand for intraocular lenses (IOLs) and glaucoma drainage devices. Another significant trend is the rise of advanced implant technologies, including multifocal and accommodating IOLs, which not only correct cataracts but also address presbyopia and other refractive errors, eliminating the need for glasses. Moreover, ongoing research in retinal implants and artificial vision devices has the potential to revolutionize treatments for retinal degenerative diseases, giving hope to patients with conditions that currently have limited treatment options. These trends are creating new opportunities in both established and emerging markets.

How Has Technology Advanced Ocular Implantation Procedures?

Technological advancements have played a critical role in improving the efficacy and safety of ocular implants. One of the key innovations is the development of premium IOLs that offer enhanced visual outcomes by correcting multiple types of refractive errors, such as astigmatism and presbyopia, in addition to cataracts. Furthermore, minimally invasive surgical techniques, such as femtosecond laser-assisted cataract surgery, have made ocular implant procedures safer and more precise, reducing recovery times for patients. Additionally, advancements in materials science have led to the development of more durable and biocompatible implant materials that minimize the risk of post-surgical complications, such as inflammation or rejection. Retinal implants, in particular, have seen remarkable progress, with devices like the Argus II providing partial vision to patients with severe vision loss caused by retinitis pigmentosa. These technological developments are revolutionizing the field of ophthalmology and driving demand for advanced ocular implants.

What Factors Are Driving the Growth of the Ocular Implants Market?

The growth in the ocular implants market is driven by several factors. First and foremost, the increasing prevalence of age-related eye disorders, particularly cataracts and glaucoma, is a major growth driver, as these conditions are most effectively treated through surgical implantation. Additionally, rising awareness and access to eye care, particularly in developing regions, are expanding the patient base for ocular implants. The growing adoption of advanced intraocular lenses (IOLs) that address multiple vision problems is another key factor. Technological advancements in ophthalmic surgery, such as improved diagnostic tools and minimally invasive techniques, are enhancing patient outcomes and contributing to the market’s expansion. Finally, the ongoing development of retinal implants and other innovative vision restoration technologies offers new hope for patients with previously untreatable conditions, further driving demand in this sector.

Select Competitors (Total 17 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â